TY - JOUR
T1 - Transcatheter Tricuspid Valve Interventions
T2 - An Emerging Field
AU - Gheorghe, Livia
AU - Rensing, Benno J.W.M.
AU - Van der Heyden, Jan A.S.
AU - Eefting, Frank D.
AU - Post, Martijn C.
AU - Rana, Bushra
AU - Swaans, Martin J.
PY - 2019/3/28
Y1 - 2019/3/28
N2 - PURPOSE OF REVIEW: This review aims to provide an updated overview and a clinical perspective on novel transcatheter tricuspid valve interventions (TTVI), highlighting potential challenges and future directions.RECENT FINDINGS: Severe tricuspid regurgitation (TR) is a predictor of mortality. However, a sizeable number of patients remain untreated until the end-stage when cardiac surgery presents a prohibitive risk. The emergent need in finding a treatment for patients with TR, deemed for surgery options, has encouraged the development of TTVI. These procedures mimic classical surgery techniques and are mainly divided in four categories: annuloplasty and coaptation devices, edge-to-edge techniques and transcatheter tricuspid valve replacement. Early studies showed promising results, but long-term follow-up data are not available. For patients with severe TR and high surgical risk, several percutaneous options are available. However, these therapies are in a growing phase and bigger studies and long term follow-up are needed to prove their efficacy.
AB - PURPOSE OF REVIEW: This review aims to provide an updated overview and a clinical perspective on novel transcatheter tricuspid valve interventions (TTVI), highlighting potential challenges and future directions.RECENT FINDINGS: Severe tricuspid regurgitation (TR) is a predictor of mortality. However, a sizeable number of patients remain untreated until the end-stage when cardiac surgery presents a prohibitive risk. The emergent need in finding a treatment for patients with TR, deemed for surgery options, has encouraged the development of TTVI. These procedures mimic classical surgery techniques and are mainly divided in four categories: annuloplasty and coaptation devices, edge-to-edge techniques and transcatheter tricuspid valve replacement. Early studies showed promising results, but long-term follow-up data are not available. For patients with severe TR and high surgical risk, several percutaneous options are available. However, these therapies are in a growing phase and bigger studies and long term follow-up are needed to prove their efficacy.
KW - Cardiac imaging
KW - Functional tricuspid regurgitation
KW - High-risk patients
KW - Transcatheter tricuspid valve interventions
KW - Tricuspid repair
KW - Tricuspid valve implantation
UR - http://www.scopus.com/inward/record.url?scp=85063980715&partnerID=8YFLogxK
U2 - 10.1007/s11886-019-1119-7
DO - 10.1007/s11886-019-1119-7
M3 - Review article
C2 - 30924027
AN - SCOPUS:85063980715
SN - 1523-3782
VL - 21
JO - Current cardiology reports
JF - Current cardiology reports
IS - 5
M1 - 37
ER -